Search for Clinical Trial Results

Sponsored By

All - 127,417 Studies Found

Status Study
Not yet recruiting Study Name: Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition
Condition: Iatrogenic Cushing's Disease
Date: 2017-03-17
Interventions:
  • Drug: AZD4017 and prednisolone

Completed Study Name: Cognition, Steroids, and Imaging in Cushings Disease
Condition: Cushing Syndrome
Date: 2004-04-08
Completed Study Name: Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Condition:
  • Cushing's Disease
  • Corticotroph Adenoma Date: 2009-04-27
    Interventions: Drug: Cabergoline Dose 1 mg/week in divided doses, increased by 1 mg/week every month, to the maximum of
Completed Study Name: A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Condition: Cushing's Syndrome
Date: 2004-07-30
Interventions: Drug: SOM230 s.c.
Completed Study Name: Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Condition:
  • Pituitary Neoplasms
  • Prolactinoma
  • ACT
    Date: 2013-01-22
    Interventions: Other: Educational Intervention A brochure and access to a website including videos that contain detaile
Completed Study Name: Effects of Hormone Stimulation on Brain Scans for Cushing s Disease
Condition: Pituitary Neoplasm
Date: 2011-10-21
Interventions: Drug: Acthrel Ovine Corticorelin
Active, not recruiting Study Name: Rhinological Outcomes in Endonasal Pituitary Surgery
Condition:
  • Pituitary Neoplasm
  • Pituitary Adenoma
  • Prolactinoma
    • Date: 2012-01-03
Completed Study Name: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
Condition:
  • Cushing's Disease
  • Acromegaly

  • Date: 2013-02-15
    Interventions: Drug: Pasireotide Pasireotide subcutaneous or Long Acting Release
Completed Study Name: Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Condition:
  • Pituitary Tumor
  • ACTH-producing Pituitary Tumour

Date: 2016-04-20
Interventions: Drug: Pasireotide LAR Pasireotide LAR (SIGNIFOR® LAR)
Terminated Study Name: Pasireotide Therapy in Patients With Nelson's Syndrome
Condition: Nelson Syndrome
Date: 2012-06-08
Interventions: Drug: Pasireotide 4 Weeks pasireotide 0.6mg s/c injections twice daily followed by 24 weeks treatment wi
<<< Previous | Next >>>